Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers

• Main Authors: Milena Matuszczak (Author), Adam Kiljańczyk (Author), Wojciech Marciniak (Author), Róża Derkacz (Author), Klaudia Stempa (Author), Piotr Baszuk (Author), Marta Bryśkiewicz (Author), Ping Sun (Author), Angela Cheriyan (Author), Cezary Cybulski (Author), Tadeusz Dębniak (Author), Jacek Gronwald (Author), Tomasz Huzarski (Author), Marcin R. Lener (Author), Anna Jakubowska (Author), Marek Szwiec (Author), Małgorzata Stawicka-Niełacna (Author), Dariusz Godlewski (Author), Artur Prusaczyk (Author), Andrzej Jasiewicz (Author), Tomasz Kluz (Author), Joanna Tomiczek-Szwiec (Author), Ewa Kilar-Kobierzycka (Author), Monika Siołek (Author), Rafał Wiśniowski (Author), Renata Posmyk (Author), Joanna Jarkiewicz-Tretyn (Author), Rodney J. Scott (Author), Steven A. Narod (Author), Jan Lubiński (Author)
• Format: Book
• Published: MDPI AG, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BRCA1 mutations predispose women to breast and ovarian cancer. The anticancer effect of zinc is typically linked to its antioxidant abilities and protecting cells against oxidative stress. Zinc regulates key processes in cancer development, including DNA repair, gene expression, and apoptosis. We to...